(1S,6R,9R)3,6,10,10-Tetramethyl-11-oxatricyclo[7.2.1.01,6]dodec-2-ene

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: (1S,6R,9R)3,6,10,10-Tetramethyl-11-oxatricyclo[7.2.1.01,6]dodec-2-ene
• 英文别名: (1S,6R,9R)-3,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.01,6]dodec-2-ene
• 化学式: C₁₅H₂₄O
• 分子量: 220.35
• InChiKey: NVLJUIWYBHDSHM-VHDGCEQUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  、 (6R/S,9R)-6methyl-9-(1-hydroxyisopropyl)-bicyclo[4.4.0]-dec-1-ene-3-one 、 、 、 氯仿 生成 (1S,6R,9R)3,6,10,10-Tetramethyl-11-oxatricyclo[7.2.1.01,6]dodec-2-ene
  参考文献：
  名称：

  Agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine

  摘要：

  式(I)所代表的化合物，其中取代基如规范和权利要求书中所定义，或其立体异构体，制备它们的过程，包含它们的药物组合物以及它们作为药物的用途。

  公开号：

  US06486201B1

文献信息

• NOVEL AGAROFUAN DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND THEIR USE AS MEDICINE
  申请人：THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES

  公开号：EP1132383A1

  公开（公告）日：2001-09-12

  The compound represented by formula (I), in which the substitutes are defined as in the specification and the claims, or their stereoisomers, the process for preparing them, pharmaceutical composition containing them and their use as medicine.

  式 (I) 所代表的化合物（其中的代用品定义见说明书和权利要求书）或其立体异构体、其制备方法、含有它们的药物组合物及其医药用途。
• US6486201B1
  申请人：——

  公开号：US6486201B1

  公开（公告）日：2002-11-26
• Agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
  申请人：Institute of Materia Medica, Chinese Academy of Medical Science (CN)

  公开号：US06486201B1

  公开（公告）日：2002-11-26

  The compound represented by formula (I), in which the substitutes are defined as in the specification and the claims, or their stereoisomers, the process for preparing them, pharmaceutical composition containing them and their use as medicine.

  式(I)所代表的化合物，其中取代基如规范和权利要求书中所定义，或其立体异构体，制备它们的过程，包含它们的药物组合物以及它们作为药物的用途。